On Tuesday, April 21, 2020, the papillomavirus research community lost one of our greats to cancer at the age of 62 – Prof. Dr. Karl Ulrich Petry. He studied Medicine from 1976 to 1983 at the Philipps-University in Marburg became assistant at the Dept. of Surgery in Remscheid and finally found his mission at the Dept. of ObGyn at the Diakonissen-Krankenhaus in Kassel. He was licensed as a physician in 1983 and moved 1986 to Tanzania at the Sokoine Regional Hospital in Lindi as Medical Officer.... read entire text
Written by Thomas Iftner, PhD Director of the Institute of Medical Virology, University Hospital Tuebingen, Tübingen, Germany
You must be logged in to leave a message.
Ulli achieved his professional recognition in many different fronts.
From a clinical epidemiology standpoint, he produced an impressive RCT on screening that would serve all the academic requirements as how to run one of such trials. It ended up with the exact expected numbers, reached the expected conclusions and interpretations and served the German medical community in clarifying these fundamental aspects of modern cervical cancer screening in German scenery. Ulli’s last contribution prepared for HPW (still unpublished) discussed vividly the public health challenges of modifying the standard Pap smear-based screening algorithms in his own country in front of the growing scientific evidence on the value of HPV tests.